Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial
Tim M. J. Ewoldt, Alan Abdulla, Wim J. R. Rietdijk, et al.
Intensive Care Medicine (2022) Vol. 48, Iss. 12, pp. 1760-1771
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With Sepsis
Giacomo Monti, Nikola Bradić, Matteo Marzaroli, et al.
JAMA (2023) Vol. 330, Iss. 2, pp. 141-141
Open Access | Times Cited: 60
Individualized antimicrobial dose optimization: a systematic review and meta-analysis of randomized controlled trials
Maria Sanz-Codina, Haktan Övül Bozkır, Anselm Jorda, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 845-857
Open Access | Times Cited: 26
Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients
François Barbier, Sami Hraiech, Solen Kernéis, et al.
Annals of Intensive Care (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 25
Model-informed precision dosing: State of the art and future perspectives
Iris K. Minichmayr, Erwin Dreesen, Marco Centanni, et al.
Advanced Drug Delivery Reviews (2024) Vol. 215, pp. 115421-115421
Open Access | Times Cited: 11
Ten reasons for the presence of pharmacy professionals in the intensive care unit
Cathrine McKenzie, Isabel Spriet, Nicole Hunfeld
Intensive Care Medicine (2024) Vol. 50, Iss. 1, pp. 147-149
Closed Access | Times Cited: 8
Beta-Lactam Dose Optimisation in the Intensive Care Unit: Targets, Therapeutic Drug Monitoring and Toxicity
Amy Legg, Sinead Carmichael, Ming G. Chai, et al.
Antibiotics (2023) Vol. 12, Iss. 5, pp. 870-870
Open Access | Times Cited: 20
Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting
Sebastian Greppmair, Alexander Brinkmann, Anka C. Roehr, et al.
Intensive Care Medicine (2023) Vol. 49, Iss. 8, pp. 966-976
Open Access | Times Cited: 16
Antimicrobial Multidrug Resistance: Clinical Implications for Infection Management in Critically Ill Patients
Gamze Kalın, Emine Alp, Arthur Chouaikhi, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2575-2575
Open Access | Times Cited: 16
The Current Status and Future Perspectives of Beta-Lactam Therapeutic Drug Monitoring in Critically Ill Patients
Emmanuel Novy, Hugo Martinière, Claire Roger
Antibiotics (2023) Vol. 12, Iss. 4, pp. 681-681
Open Access | Times Cited: 15
Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients—A Narrative Review
Jan Stašek, Filip Keller, Veronika Kočí, et al.
Antibiotics (2023) Vol. 12, Iss. 3, pp. 568-568
Open Access | Times Cited: 14
Advancing precision-based antimicrobial dosing in critically ill patients
Menino Osbert Cotta, Jeffrey Lipman, Jan J. De Waele
Intensive Care Medicine (2023) Vol. 49, Iss. 3, pp. 324-326
Open Access | Times Cited: 13
Individualization of piperacillin dosage based on therapeutic drug monitoring with or without model-informed precision dosing: a scenario analysis
David Haefliger, Leonardo Mina, Monia Guidi, et al.
Journal of Antimicrobial Chemotherapy (2025)
Open Access
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Nobuaki Shime, Taka‐aki Nakada, Tomoaki Yatabe, et al.
Acute Medicine & Surgery (2025) Vol. 12, Iss. 1
Open Access
Cystatin C-Guided Dosing Nomogram Improves Target Attainment for Cefepime in the Critically Ill
Erin F. Barreto, Marc H. Scheetz, Jack Chang, et al.
Critical Care Medicine (2025)
Closed Access
Antibiotic dosing optimization in critically ill patients
Despoina Koulenti, Claire Roger, Jeffrey Lipman
Intensive Care Medicine (2025)
Closed Access
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Nobuaki Shime, Taka-aki Nakada, Tomoaki Yatabe, et al.
Journal of Intensive Care (2025) Vol. 13, Iss. 1
Open Access
Standard versus double dosing of beta-lactam antibiotics in critically ill patients with sepsis: The BULLSEYE study protocol for a multicenter randomized controlled trial
M. M. B. Horstink, Dieuwertje R. Geel, Corstiaan A. den Uil, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Antimicrobial activity and mechanism of gallic acid- gadolinium complex against multidrug-resistant Salmonella
Xian Liu, Qiwu Yuan, Yang Yang, et al.
Industrial Crops and Products (2025) Vol. 229, pp. 120980-120980
Open Access
The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care setting
Rekha Pai Mangalore, Trisha Peel, Andrew Udy, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 10, pp. 2395-2405
Open Access | Times Cited: 12
Salivary Therapeutic Drug Monitoring of Antimicrobial Therapy: Feasible or Futile?
Lina Davies Forsman, Hannah Yejin Kim, Thi Anh Nguyen, et al.
Clinical Pharmacokinetics (2024) Vol. 63, Iss. 3, pp. 269-278
Open Access | Times Cited: 4
Pharmacokinetic Factors Associated With Early Meropenem Target Attainment in Pediatric Severe Sepsis
Kelli Paice, Sonya Tang Girdwood, Tomoyuki Mizuno, et al.
Pediatric Critical Care Medicine (2024)
Closed Access | Times Cited: 4
Individualised dosing of antibiotics in ICU patients: timing, target and model selection matter
Uwe Liebchen, Josef Briegel, Alexander Brinkmann, et al.
Intensive Care Medicine (2023) Vol. 49, Iss. 4, pp. 475-476
Open Access | Times Cited: 10
Training the next generation of pharmacometric modelers: a multisector perspective
Peter L. Bonate, Jeffrey S. Barrett, Sihem Ait‐Oudhia, et al.
Journal of Pharmacokinetics and Pharmacodynamics (2023) Vol. 51, Iss. 1, pp. 5-31
Closed Access | Times Cited: 9
Can precision antibiotic prescribing help prevent the spread of carbapenem-resistant organisms in the hospital setting?
Vasin Vasikasin, Timothy M. Rawson, Alison Holmes, et al.
JAC-Antimicrobial Resistance (2023) Vol. 5, Iss. 2
Open Access | Times Cited: 8
What’s new in therapeutic drug monitoring of antimicrobials?
Fredrik Sjövall, Christian Lanckohr, Hendrik Bracht
Intensive Care Medicine (2023) Vol. 49, Iss. 7, pp. 857-859
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top